Efficacy of a trivalent influenza vaccine against seasonal strains and against 2009 pandemic H1N1: A randomized, placebo-controlled trial
Under a Creative Commons license
open access
Keywords
Cross-protection
Influenza A virus
H1N1 subtype
Influenza vaccine efficacy
Seasonal influenza
Seasonal trivalent inactivated influenza vaccine
Cited by (0)
- 1
Present address: Modelling and Simulation Unit, Melbourne School of Population and Global Health, The University of Melbourne, Victoria 3010, Australia and Murdoch Childrens Research Institute, Parkville, Victoria 3052, Australia.
- 2
Present address: Hartel Consulting, Brisbane, Queensland 4170, Australia.
- 3
Present address: Novartis Pharma AG, Retina Development Franchise, Novartis Campus, 4056 Basel, Switzerland.
- 4
Present address: Sanofi Pasteur, San Francisco, CA 94107, USA.
© 2016 The Authors. Published by Elsevier Ltd.